Hyperglycolysis, observed within the penumbra zone during brain ischemia, was shown to be detrimental for tissue survival because of lactate accumulation and reactive oxygen species overproduction in clinical and experimental settings. Recently, mounting evidence suggests that glycolytic reprogramming and induced metabolic enzymes can fuel the activation of peripheral immune cells. However, the possible roles and details regarding hyperglycolysis in neuroinflammation during ischemia are relatively poorly understood. Here, we investigated whether overactivated glycolysis could activate microglia and identified the crucial regulators of neuroinflammatory responses in vitro and in vivo. Using BV 2 and primary microglial cultures, we found hyperglycolysis and induction of the key glycolytic enzyme hexokinase 2 (HK2) were essential for microglia-mediated neuroinflammation under hypoxia. Mechanistically, HK2 up-regulation led to accumulated acetyl-coenzyme A, which accounted for the subsequent histone acetylation and transcriptional activation of interleukin (IL)-1b. The inhibition and selective knockdown of HK2 in vivo significantly protected against ischemic brain injury by suppressing microglial activation and IL-1b production in male Sprague-Dawley rats subjected to transient middle cerebral artery occlusion (MCAo) surgery. We provide novel insights for HK2 specifically serving as a neuroinflammatory determinant, thus explaining the neurotoxic effect of hyperglycolysis and indicating the possibility of selectively targeting HK2 as a therapeutic strategy in acute ischemic stroke.
Ischemic stroke is ranked as the second leading cause of death and disability (Feigin et al. 2014; Chamorro et al. 2016) . Although significant advances have been made in preclinical research, the reality of clinical translation is rather dismal (George and Steinberg 2015) and further exploration of ischemic stroke pathogenesis is required to fully understand this devastating illness.
Enhanced glucose metabolic rates relative to oxygen, known as hyperglycolysis, are triggered by diminished blood supply during brain ischemia in the penumbra zone (Tohyama et al. 1998; Nasu et al. 2002; Kochanski et al. 2013) . Hyperglycolysis reportedly compromises salvageable tissues because of lactic acidosis and enhanced reactive oxygen species (ROS) production (Kochanski et al. 2013) . Noxious overactivated glucose metabolic effects are more pronounced in stroke patients with hyperglycemic milieu (Wass and Lanier 1996; Dungan et al. 2009 ). Consistent with the observations above, the neuroprotective effects of N-methyl-D-aspartate (NMDA) antagonists or ethanol in middle cerebral artery occlusion (MCAo) models are partially associated with repressed glucose metabolism (Zeevalk and Nicklas 1993; Kochanski et al. 2013) . Furthermore, moderate hypothermia in stroke patients is associated with attenuating glucose utilization and overactivated glycolysis (Tohyama et al. 1998; Berger et al. 2002) .
Emerging evidence has recently indicated reciprocal regulation between glucose metabolism and immunity (Nakaya et al. 2014; O'Neill and Pearce 2016) . Studies suggest that enhanced glycolysis promoted by pyruvate kinase M2 (PKM2) provides substrates for the biosynthesis of proteins and nucleic acids required for the inflammatory activation of immune cells primed by lipopolysaccharides (LPS) in the periphery (Everts et al. 2014; Yang et al. 2014; Palsson-McDermott et al. 2015) . During the onset and progression of acute ischemic stroke, microglia-mediated neuroinflammation is a well-defined element (Fu et al. 2015) . As sentinels of the central nervous system, microglia sense the damage-associated molecular pattern molecules released during ischemia and initiate an uncontrolled early brain inflammation (Bartels et al. 2013) by releasing inflammatory cytokines, chemokines, ROS, etc. (Brown and Vilalta 2015; George and Steinberg 2015; Chamorro et al. 2016) . However, besides lactate accumulation and ROS production, the roles of enhanced glycolysis in ischemic brain injury via neuroinflammation remain unclear.
As the first rate-limiting enzyme in glycolysis, hexokinase (HK) has four isoforms in mammalian cells, which convert glucose to glucose-6-phosphate with distinct spatial-temporal distribution patterns (Wilson 2003) . Generally, HKs 1, 3, and 4 mainly function in adult differentiated tissues, whereas hexokinase 2 (HK2) is typically induced in pathological settings. Recent studies have suggested that HK-dependent glycolysis promotes inflammasome activation, providing a clue for the involvement of HKs in regulating immune responses (Everts et al. 2014; Moon et al. 2015) . Nonetheless, whether HK family members are the molecular determinants responsible for the inflammatory activation of microglia remains unknown, especially in hypoxic condition.
In this study, to explore the role of hyperglycolysis in microglial activation and therefore the pathological basis for acute ischemic stroke, we first used a 1% oxygen atmosphere to mimic the ischemic environment to study glucose metabolism alterations and their effects on neuroinflammation. Our results show that the commitment to glycolysis is essential for microglial activation and that HK2 specifically dictates inflammatory response during hypoxic exposure. Hypoxia elicits an HK2-dependent acetyl-coenzyme A accumulation, which accounts for the histone acetylation and transcriptional induction of proinflammatory cytokine interleukin (IL)-1b. Furthermore, both the pharmacologic and genetic inhibition of HK2 significantly protect rats from ischemic brain injuries. Taken together, these data suggest that HK2 induction is critical for the hyperglycolysisassociated detrimental effects during stroke, thus presenting HK2 as a promising target for the treatment of acute ischemic stroke.
Methods
Cell culture BV 2 cells were purchased from China Center for Type Culture Collection. It is not listed as a misidentified cell line by the International Cell Line Authentication Committee. Cells were cultured in Dulbecco's modified Eagle's medium (Gibco, Rockville, MD, USA, 11965-118) with 10% fetal bovine serum (FBS) (Gibco, 10099-141) . For the isolation and culture of primary microglia, cells were isolated from newborn C57BL/6J mice as previously described (Sedgwick et al. 1991) with slight modifications. Briefly, cerebral cortices devoid of meninges and blood vessels were dissociated from P0-2 mice and digested by 0.125% trypsin for 15 min. Isolated cells were then plated on 25 cm 2 flasks previously coated with poly-L-lysine (5 lg/mL). After the mixed cultures became confluent, microglia were separated from other cell types by slight shaking and purification was identified by the microglial-specific marker CD 11b.
Immunofluorescence imaging
For cell immunofluorescence experiments, samples were fixed in 4% paraformaldehyde for 15 min and incubated in 0.2% Triton X-100 for 20 min at 25°C, and then washed three times in phosphate-buffered saline containing 0.1% (v/v) Tween-20 (PBST). The cells were then incubated with the indicated primary antibodies overnight at 4°C in DAKO antibody Diluent with Background Reducing Components (S3022). The next day, samples were washed and incubated with fluorescence-conjugated secondary antibodies (1 : 1000, Molecular Probes) for 1 h. Images were captured with a Nikon A1 spectral confocal microscope. For brain sections, slices were deparaffinized, hydrated, and subjected to the same procedures as described above after antigen retrieval. The mean fluorescence intensities of target proteins were analyzed with Nikon A1 spectral confocal microscope analysis system by another investigator.
Immunohistochemistry
Brain slices were prepared according to manufacturer's instructions (Abcam, Cambridge, MA, USA, ab80436). Briefly, samples were deparaffinized and hydrated, and subjected to antigen retrieval. After being cooled to 25°C, samples were incubated in indicated primary antibodies overnight at 4°C in DAKO Antibody Diluent with Background Reducing Components (S3022). The next day, samples were washed in phosphate-buffered saline, subjected to serial incubation in complement and an horseradish peroxidase (HRP) conjugate, and a 3,3
0 -diaminobenzidine tetrahydrochloride substrate-chromogen mix was applied to the tissues. Finally, counter-staining was performed and images were captured with a Nikon ECLIPSE Ti microscope by another researcher. To quantify the immunoreactivity profiles of IL-1b,the photos were processed and analyzed using Image-Pro Plus 6.0 software (Silver Springs, MD, USA) by a third researcher.
2-NBDG uptake assay
Prior to the experiment, the cell medium was replaced with Dulbecco's phosphate-buffered saline (DPBS) containing 200 lM 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose (2-NBDG, Thermo Fisher Scientific, San Jos e, CA, USA, N13195), and cells were then cultured in normoxic or hypoxic conditions. After 1 h of incubation, the medium was exchanged for fresh DPBS for another 5 min to allow the efflux of non-phosphorylated 2-NBDG. Finally, images were captured and 2-NBDG uptake was quantified with a fluorescence microplate assay.
Western blotting
Total proteins were extracted with M-PER TM Mammalian Protein Extraction Reagent (Thermo Fisher Scientific, 78503) supplemented with protease inhibitor cocktail (Millipore Corporation, Bedford, MA, USA, 539131-10 VL), and concentrations were determined by the bicinchoninic acid protein assay (Thermo Fisher Scientific, 23225) . After 20 lg of total proteins were loaded and separated on 10%/15% SDS-PAGE gels, western blotting analysis was performed using antibodies against HK1 (Abcam, 150423, 1 : 1000) 
Metabolite extraction and LC-MS analysis
For metabolite profiling, metabolites were extracted from cells grown in 60-mm culture dishes using 1.5 mL of icecold 80% methanol. After incubation at À80°C for 30 min, cells were scrapped and centrifuged at 14 000 g for 15 min at 4°C. The upper methanol/water phase were transferred into new tubes and incubated at À80°C for another 30 min. The upper phases were centrifuged and dried under nitrogen gas and dried samples were stored at À80°C prior to analysis.
RNA interference assays
Short-interfering RNAs (siRNAs) targeting HK1, HK2, HK3, and PKM2 were transiently transfected into BV 2 microglia with Lipofectamine RNAiMAX Reagent (Invitrogen, Carlsbad, CA, USA, Thermo Fisher Scientific, 13778-500) using the protocol provided by the manufacturer. In total, 50 nM siRNAs were transfected into the cultures, and after 12 h, the medium was replaced with fresh Dulbecco's modified Eagle's medium supplemented with 10% FBS. Proteins were collected as described above to validate the effectiveness of the siRNAs.
Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation assays were performed as described in a commercial manual (Millipore, . BV 2 cells were treated with dimethylsulfoxide or lonidamine for 1 h prior to hypoxic exposure. Then, cells were cross-linked with a 1% formaldehyde solution (Sigma, F8775) for 10 min at 37°C. Cell lysates were sonicated to generate 100-1000 bp DNA fragments and the sonication conditions were as follows: 100 watts, 50% output, 10 s on and 50 s off for five cycles. Samples were diluted, and 10% of the total amount was retained for input. The remaining portions of each sample were pre-cleared, and anti-H3 or anti-H4 antibodies were added; a normal rabbit IgG antibody was simultaneously used as the negative control. The next day, protein G agarose was added and samples were washed after 2 h of incubation. Cross-links were then reversed by incubation at 65°C for 4 h in 0.2 M NaCl. DNAs were extracted from the input and IP samples, and qPCR assays were performed. The Il1b promoter primer sequences were as follows: 5 0 -AGGTCAAAGGTTTGGAAGCAG-3 0 and 5 0 -ATGGAAGTCTGTCTGCTCAGTATTG-3 0 .
Middle cerebral artery occlusion (MCAo) model
The Adult male Sprague-Dawley rats (RRID: RGD_8547938) were purchased from The Animal Center of Sun Yat-Sen University. For the animals used in Figs 5 and 6, the rats weighed 260-280 g and 80-100 g, respectively. Rats were housed in a temperature and humiditycontrolled animal center that was maintained under filtered positive-pressure ventilation on a 12 h light/12 h dark cycle. Every five rats were kept in a cage and given ad libitum access to food and water. MCAo surgery was performed on male as previously reported (Hu et al. 2014) . From our previous experiments, SDs are about 15-20% of the mean infract volume in the model we are using in our laboratory. We set power at 0.8 and a at 0.05 to calculate the sample size for each treatment group. Before surgery, animals were fasted overnight, but received drinking water. The next day, rats were weighed and anesthetized with sodium pentobarbital by intraperitoneal injection at a dose of 60 mg/kg. Then unilateral common carotid and external carotid artery were exposed and ligated. To introduce MCAo, a 0.28-mm nylon monofilament with a silicone-coated tip was inserted into the internal carotid artery. After 120 min of ischemia, reperfusion was accomplished by withdrawing the nylon monofilament. To minimize animal discomfort and stress during surgery, the main handling procedures necessary were trained beforehand and all surgery was performed under anesthesia. The left femoral artery was cannulated for the continuous monitoring of physiological indices. The body temperature was measured and maintained at 37.5°C AE 0.5°C through a heating pad. After surgery, animals were given to soft food. After 24 h, the rats were anesthetized deeply with sodium pentobarbital by intraperitoneal injection at a dose of 100 mg/kg and decapitated. Rats were excluded from analysis only if they died before reperfusion. Brain tissues were frozen and sliced with a microtome into five coronal sections (2-mm thick). The sections were then incubated in 1.0% 2,3,5-triphenyltetrazolium chloride (TTC) at 37°C for 20 min and fixed in a 4.0% paraformaldehyde solution overnight. After TTC staining, determination of infarct size was carried out by an independent investigator. For each coronal slice, the infarct tissue (unstained area) and total bihemispheric area were delineated in the scanned image with Adobe Photoshop CS6. The infarcted volume was calculated as the ratio of the total unstained areas (white) over the total bihemispheric area. During the whole procedure, investigators were blinded with the treatment group. The study was not pre-registered. Animal experiments were approved by the Ethics Committee of ZSSOM on Laboratory Animal Care (No. 2015-122) . All efforts were made to minimize animal suffering and to reduce the number of animals used.
Recombinant AAV2/9-shHK2 plasmid construction Recombinant adeno-associated virus (rAAV) vectors [pAAV-CAG-eGFP-U6-shRNA, constructed by Obio Technology (Shanghai) Corp., Ltd.] carrying shRNAs to rat HK2 and eGFP or eGFP alone were used to produce rAAV in 293T cells by transfection. The genomic titers of the viruses ranged from 3.2 9 10 12 to 3.5 9 10 12 V.G./mL, as determined by qPCR. To construct the AAV2/9 vectors, the following sequences targeting HK2 were used: 5 0 -GCGCAA-CATTCTCATCGATTT-3 0 and 5 0 -AAATCGATGAGAAT GTTGCGC-3 0 . The control shRNA sequence was 5 0 -TTCT CCGAACGTGTCACGT-3 0 .
Stereotaxic injection
In total, 2 lL of the viral vectors was injected unilaterally into the striata of anesthetized rats fixed in a stereotaxic frame using a 10-lL microsyringe. The injection site coordinates were: 1.0 mm rostral to bregma, 3.0 mm lateral to the midline, and 4.5 mm ventral to the dura, with the tooth bar set to zero. Microinjections were carried out at a rate of 0.2 lL/min using a laboratory syringe infusion pump (Kd Scientific, KDS 310 plus). After injection, the microsyringe remained in situ for an additional 5 min before being withdrawn.
Statistical analysis
Acquired data first were tested for normal distribution with a Shapiro-Wilk test. The data were normally distributed, hence they were analyzed with GraphPad Prism 6 software (San Diego, CA, USA) and are presented as the mean AE SD. Two-group comparisons were assessed using Student's twotailed t-tests, and ANOVA (with post hoc comparisons using Dunnett's test) was used to analyze multiple groups. p-values less than 0.05 were considered statistically significant.
Results

Glycolytic reprogramming contributes to microglial activation under hypoxia
To elucidate the possible role of hyperglycolysis in microglia inflammation during ischemia, BV 2 microglial cells were cultured in hypoxic environment (1% oxygen) for the indicated times. As shown in Fig. 1a and b, hypoxia stimulation led to profound morphological changes in BV 2 cells, with enlarged cell bodies and filopodia or lamellipodia formation being observed as well as enhanced expression of CD 11b (Fig. 1c) , a molecular marker of microglial activation (Roy et al. 2006) . In addition, pro-inflammatory cytokine production was markedly induced in a timedependent manner (Fig. 1d) . Notably, 24 h of hypoxic exposure caused no obvious cell death, as evidenced by no increases in the numbers of Annexin V + or PI + BV 2 cells ( Fig. 1e and f) .
Next, glycolytic flux was assayed by glucose uptake using a fluorescent analogue of glucose 2-NBDG (Chen et al. 2015) and metabolite profiling using LC-MS. As depicted in Fig. 1g and h, 2-NBDG uptake was increased by 1.6-fold after 1 h of hypoxic exposure, and no morphological changes were observed at this time point. Metabolic profiling also showed a significantly elevated abundance of metabolic intermediates of the glycolytic pathway, including fructose-1, 6-biphosphate, dihydroxyacetone phosphate and glyceraldehyde 3-phosphate (G-3-P) (Fig. 1i) . Of particular note are the slight increases of Glucose-6-phosphate (G-6-P) and NADPH after hypoxic stimulation for 6 h, although both of their accumulation is not significant. Given the fundamental role of glycolytic reprogramming in LPS-activated immune cells (Everts et al. 2014; Yang et al. 2014) , we sought to identify whether it was responsible for hypoxiainduced microglial activation. In the presence of 500 lM 2-deoxyglucose (2-DG), an effective inhibitor of glycolysis (Everts et al. 2014) , the percentage of BV 2 cells with activated morphological changes (Burguillos et al. 2011) decreased to 11.0% after hypoxic exposure ( Fig. 1j and k) . In addition, the hypoxia-stimulated the up-regulation of the effector cytokines TNF-a,IL-1b, and IL-6 was substantially inhibited (Fig. 1l) . Collectively, these data demonstrate that enhanced glycolysis is essential for microglial activation after hypoxia exposure.
Hexokinase 2 induction is exclusively responsible for hypoxia-activated microglia To determine whether specific metabolic enzyme(s) that are responsible for microglial activation exist, the expression levels of glycolytic enzyme genes (Fig. 2a) were screened in an unbiased manner in BV 2 cells. After 6 h of hypoxia, an overall up-regulation of the mRNA levels of these enzymes was detected (Fig. 2b) , including PKM2 (Fig. 2b and c) . Given the critical role of PKM2 in LPS-primed macrophages (Yang et al. 2014; Palsson-McDermott et al. 2015b) , we assumed it may also be indispensable for hypoxia-induced microglial activation. Surprisingly, neither increased CD 11b expression (Fig. 2d ) nor morphological changes (Fig. 2e) induced by hypoxia were inhibited by PKM2 knockdown.
Of note, HK, the first rate-limiting enzyme in glycolysis, was of particular interest. All three HK isoforms tested exhibited increased mRNA expression (Fig. 2b) . Further results showed protein expression of these isoforms also (2-NBDG) uptake assays in cells incubated with 2-NBDG exposed to normoxia or hypoxia for 1 h. Scale bar, 100 lm. (h) The mean fluorescence intensity in (g) was quantified using a multi-detection microplate reader (n = 4). (i) Graphs illustrating key metabolites in the glycolytic pathway; the significantly enhanced metabolites were marked after exposure to hypoxia for 6 h (n = 4). (j-l) 2-DG, an inhibitor of the glycolytic pathway, significantly blocked microglia activation during hypoxia. (j) Phase contrast images of BV 2 cells subjected to 1% oxygen with or without 2-DG. (k) Decreased percentage of activated cells after the 2-DG treatment in (j). Scale bar, 50 lm (n = 4). (l) The production of proinflammation cytokines was significantly impaired by 2-DG under hypoxia. *<0.05; **<0.01; ***<0.001.
exhibited transient or sustained increases in BV 2 (Fig. 3a , left panel) and primary microglia cells (Fig. 3a, right panel) . We noticed a more dramatic increase in HK2 than HK1 and HK3 as early as 6 h after hypoxia (Fig. 3a) , strongly suggesting the important role of HK2 in microglial activation.
To determine their relative contributions to the activated microglia state, siRNAs specific to HK1, HK2, and HK3 were transfected into BV 2 cells. Unexpectedly, neither HK1 nor HK3 knockdown was capable of blocking microglial activation (Fig. 3e and f) . Only upon HK2 knockdown could the activated phenotype be significantly inhibited ( Fig. 3b-d) . Silencing HK2 expression using the #2 and #3 fragments (Fig. 3b) led to the percentage of microglia with activated morphologies being diminished from 52.1% to 25.1% and 25.3%, respectively (Fig. 3c) , which was also accompanied by the diminished expression of CD 11b (Fig. 3d) . Notably, the siRNAs targeting HK2 had no effect on HK1 and HK3 expression (Fig. 3b) , further demonstrating the exclusive and causative role of HK2 in inflammatory activation.
To extend our results on primary isolated microglia, pharmacological inhibitor of HK2, lonidamine was used to confirm the decisive role of HK2 in controlling inflammatory responses. Likewise, an impairment in both BV 2 and primary microglial activation in the presence of lonidamine under hypoxia was observed, as evidenced by the reduced number of cells with activated morphologies (Fig. 3g and h ) and diminished CD 11b expression (Fig. 3i) . Altogether, these data suggest that HK2 up-regulation is exclusively accountable for hypoxiainduced microglial activation.
Hexokinase 2 induction leads to increased histone acetylation and translational activation of Il1b
Considering accumulating data suggesting that metabolites generated in LPS-stimulated immune cells are critical for their activation and effector functions (O'Neill and Pearce 2016), we next explored the effect of HK2 up-regulation on metabolic flux in microglia activation. After hypoxia stimulation for 6 h, metabolic changes in the glycolysis, TCA cycle and pentose phosphate pathways in BV 2 cells were monitored as described in Fig. 4a . Surprisingly, succinate buildup, considered an inflammatory signal in LPS-activated macrophages (Tannahill et al. 2013) was not observed (Fig. 4b, left panel) . Acetyl-coenzyme A was most significantly affected by hypoxia, as a 3.2-fold increase in its expression was observed (Fig. 4b, right panel) . Knowing that histone acetylation has a profound effect on the transcriptional regulation of inflammatory responses (Matt 2002; Schmidt et al. 2016) , we assessed whether accumulated acetyl-coenzyme A could provide substrates for histone acetylation to sustain microglial activation. As shown in Fig. 4c (left panel) , the acetylated histones 3 and 4 were markedly up-regulated, which is a hallmark of open chromatin structure and transcriptional activation (Wang et al. 2012; Covarrubias et al. 2016) . Consistent with the expression profiles of HK family members, elevated histone acetylation was also observed at later time points in primary microglia cells (Fig. 4c, right panel) . Because previous studies have reported that enhanced glycolytic flux can cause global histone acetylation and because of the important role of HK2 in promoting glycolysis (Friis et al. 2009 ), we examined whether HK2 induction is required for the transcriptional events for microglial activation. Clearly, in the presence of HK2 inhibitors lonidamine and 3-Brpyruvate (BrPA) (Zhang et al. 2014) , the hypoxia-induced accumulation of acetyl-coenzyme A (Fig. 4d ) and histone acetylation (Fig. 4e) were remarkably impaired. Next, quantitative reverse transcription polymerase chain reaction assays were performed to examine the mRNA levels of several proinflammatory cytokines in the presence or absence of HK2 inhibitors. Lonidamine and BrPA dramatically inhibited hypoxia-induced Il1b expression at the mRNA level but had no effect on Tnfa and Il6 expression (Fig. 4f) . To explore how diminished acetylated histones affected the transcriptional expression of Il1b, chromatin immunoprecipitation assays were carried out to examine endogenous binding of acetylated histones to Il1b promoter. The binding of AcH3 and AcH4 to the Il1b promoter increased during hypoxia, whereas it could be decreased by lonidamine (Fig. 4g) . Overall, our data reveal a novel role for the HK2-mediated transcriptional induction of Il1b through promoting the generation of intracellular acetyl-coenzyme A and histone acetylation, which provides new insights into explaining hyperglycolysis-mediated neurotoxic effect.
Hexokinase 2 blockade prevents ischemic brain injury through repressing microglia-mediated neuroinflammation in an experimental stroke model Microglia-mediated neuroinflammation is a characteristic feature of numerous neurological diseases, including ischemic stroke (Macrez et al. 2011; Valdearcos et al. 2014) . A growing awareness exists that harnessing inflammatory response during ischemia can be a promising therapeutic approach (Bartels et al. 2013; Fu et al. 2015b ). Since our results implied that HK2-driven hyperglycolysis is a potent inducer of brain inflammation, we aimed to investigate whether HK2 inhibition could exert neuroprotective effect on a rat transient MCAo model of focal ischemia. Before surgery, animals were divided into four groups according to a randomized table generated by SPSS software. As shown in Fig. 5a -c, 2 h after occlusion, lonidamine administration effectively protected rat brains from ischemic damage by significantly reducing the infarct size by up to 50%,indicating that the inhibition of enhanced glycolysis is critical for the tissue survival in the penumbra.
To further identify the causative role of HK2 inhibition in rescuing infarct lesions was via suppressing microgliamediated neuroinflammation, shRNA targeting HK2 was also delivered unilaterally to the striatum using rAAV 3 weeks before surgery ( Fig. 6a and b) . Animal weights were monitored constantly, and no statistical significance was detected 20 days after AAV vector injection. (Animal weights in the AAV2/9-shNC and AAV2/9-shHK2 group were 273.2 AE 6.9 g and 269.3 AE 5.0 g, respectively; p = 0.66). Before surgery, whole-brain tissues from rats were collected to detect the spread of AAVs using in vivo optical imaging technology based on eGFP expression (Fig. 6c) . As seen in Fig. 6d , because of the disseminated distribution of AAVs, the HK2 up-regulated by MCAo surgery was effectively inhibited, whereas the activation marker CD 11b was positively correlated with HK2 expression in microglia. Similar to HK2 inhibition, TTC staining showed infarct sizes reduced by 3.7-fold in HK2-knockdown rats compared to their counterparts injected with AAVs carrying control shRNA ( Fig. 6e and f) .
To confirm that the neuroprotective effect of HK2 knockdown was because of repressed inflammatory responses, brain tissues from these subjects were stained for another microglial activation marker Iba-1 (Imai and Kohsaka 2002) . As seen in Fig. 7a , the neuroprotective effect of HK2 knockdown was associated with the prominent inhibition of Iba-1 expression (Fig. 7b) , and HK2 knockdown significantly reduced the accumulation of microglia in the infracted hemisphere (Fig. 7c) . Moreover, as revealed in Fig. 7a , microglia in the shNC group had morphological characteristic of activated microglia, with the enlargement of cell bodies and retraction of projections, whereas their activated morphologies were markedly repressed in the shHK2 treatment group. Further analysis showed widely diffused expression of the proinflammatory cytokine IL-1b in the cortex, and the striatum of the ischemic hemisphere was remarkably reduced upon HK2 knockdown ( Fig. 7d and e) .
Altogether, we provide evidence herein that HK2 blockade can prevent ischemic brain injury through repressing microglia-mediated neuroinflammation. Our data define HK2, a key glycolytic enzyme, as a promising target for the treatment of ischemic brain injury via repressing neuroinflammation.
Discussion
Enhanced glycolysis within penumbra during ischemic stroke is well known to cause brain damage because of the accumulation of lactate and oxidative stress, but its role in neuroinflammation has not been elucidated. In this study, we found that enhanced glycolysis is also involved in microglia-mediated inflammatory injury during stroke, and we identify HK2 as the major determinant. Furthermore, we demonstrate that HK2 is a novel epigenetic regulator of microglia-mediated inflammation. Our data shed new light on the neurotoxic effect of hyperglycolysis in an HK2-dependent manner and provide evidence for harnessing this molecule as a therapeutic intervention during ischemic stroke. As key enzymes in glycolysis, HK and PK family members share similar expression patterns regarding their temporal and regional distribution. Specifically, in physiological conditions, adult brain tissues usually use HK1 and PKM1 to fulfill the glycolytic process, whereas tumor and inflammatory diseases normally see an induction of HK2 and PKM2 (Hitosugi et al. 2009; Patra et al. 2013) . The inhibition of PKM2 has shown encouraging results against infectious diseases in peripheral tissues (Tannahill et al. 2013; Yang et al. 2014; Palsson-McDermott et al. 2015) . Studies have found that PKM2 acts as a major player in LPSinduced macrophage activation through stabilizing HIF-1a (Tannahill et al. 2013; Yang et al. 2014) . In our research, we indeed found PKM2 was induced during hypoxic exposure, but similar to HK1 and HK3, PKM2 did not contribute to microglial activation. We speculate that this finding is because of the fact that HIF-1a is stabilized prior to PKM2 induction in hypoxic environment, which may also account for the up-regulated PKM2 and IL-1b expression (Luo and Semenza 2012; Yang et al. 2014) . Apart from this, our metabolite screening data suggest that metabolites accumulated/depleted during hypoxia-induced microglial activation are also markedly different from those in LPS-primed peripheral immune cells (Palsson-McDermott et al. 2015) . The above observations may be attributed, at least partially, to the distinctive regulatory mechanisms of inflammatory response in response to different stimuli. Our observations also provide insights into why some anti-inflammatory agents cannot be used successfully to clinically treat ischemic stroke (Chamorro et al. 2016) . Our data link hyperglycolysis with neuroinflammation in an HK2-dependent fashion and strongly suggest that selectively inhibiting HK2 induction can be a novel treatment strategy for ischemic stroke.
Here, we provide evidence for the neuroprotective effect of HK2 inhibition in the early stages of stroke through repressing inflammatory responses. Inhibition of acute inflammatory response after stroke is well documented to decrease injury and improve neurological outcomes in rodent stroke models (Arac et al. 2011) . In agreement with previous reports, our results indicate that the selective inhibition of HK2 blocks microglial activation and significantly alleviates infarction size at 24 h after the onset of ischemic stroke in vivo. However, the immune system is a double-edged sword, as it not only plays a deleterious role in the CNS's response to ischemic attack during the early stage but also functions in the eventual recovery. Microglial activation is the key initial step in response to ischemic insult, which is followed by later events such as blood-brain barrier breakdown and post-stroke tissue remodeling. Residential brain immune cells and the influx of peripheral immune cells are both involved in post-stroke immune response events. More studies are required to evaluate the role of HK2 in the inflammatory responses in other immune cells during ischemia and the effect of HK2 inhibition in poststroke recovery to validate HK2 as a therapeutic target for stroke.
HK2 drives microglia activation via transcriptionally regulating the proinflammatory mediator IL-1b, which provides a novel explanation for the neurotoxicity of hyperglycolysis. Enhanced glycolysis is believed to be a hallmark of the inflammatory phenotype in LPS-primed peripheral immune cells (Everts et al. 2014; Yang et al. 2014) , and the metabolic intermediates, including glycolysis, have been identified as inflammatory signal molecules (Tannahill et al. 2013; Nakaya et al. 2014b) . As the first rate-limiting enzyme in glycolytic pathway, few studies about hexokinase family have focused on their metabolic role in supporting the anabolic demands for the activation of dendritic cell and promoting NLRP3 inflammasome activation through glycolytic burst (Moon et al. 2015) . More recently, a study reported that hexokinase can function as a pattern recognition receptor to recognize bacterial peptidoglycan and trigger inflammasome activation (Wolf et al. 2016) , further supporting the involvement of HK family members in inflammatory regulation. Here, our study on HK2 bridges hyperglycolysis and neuroinflammation through a novel mechanism of transcriptionally regulating the proinflammatory mediator IL-1b. However, HK2 may feasibly be involved in lactate accumulation and ROS induced by hyperglycolysis. Our data here confirm HK2 inhibition can effectively prevent brain injury from ischemic stroke. Apart from this, the selective inhibition of HK2 might provide additional therapeutic safety benefits, as HK2 is typically inducible in pathological settings, whereas HK1 is constitutively expressed in normal adult brains for fuel provision.
Epigenetic insights into the regulation of inflammatory responses have emerged with conflicting results (Das Gupta et al. 2016; Devaiah et al. 2016) . Some studies performed on LPS-primed peripheral immune cells suggest that the recognition of acetylated histones, a dynamic process mediated by histone acetylases and histone deacetylases (HDACs), is crucial for initiating the mRNA transcription of proinflammatory genes (Devaiah et al. 2016) . Nevertheless, this finding is counteracted by the fact that many HDAC inhibitors have shown anti-inflammatory properties (Falkenberg and Johnstone 2014; Das Gupta et al. 2016) . The different models used may account for these disagreements, yet the paradoxes also suggest that epigenetic regulation of inflammatory responses may be stimulus-or cell-dependent. Here, we showed in hypoxia-stimulated microglia, not only an enhanced histone acetylation but also the subsequent transcriptional activation of proinflammatory cytokine IL-1b is observed. We further demonstrated that HK2 plays a significant role in controlling microglial activation via an epigenetic way of selectively affecting the generation of acetyl-coenzyme A and histone acetylation. We found that the hyperglycolysis-induced accumulation of acetyl-coenzyme A is crucial for epigenetics-regulated neuroinflammation in hypoxia-activated microglia and further add that this is an HK2-dependent situation. However, in terms of HK2-dependent histone acetylation, we speculate it also may be caused by (i) Sirt1, a class III HDAC member, has been reported a repressed expression under hypoxia, which may also be responsible for the overacetylated state (Shin et al. 2014) . HK2 may regulate the upstream effectors in histone acetylation, including activities of histone acetylases and HDACs, thus fulfilling the transcriptional regulation of IL-1b. and (ii) Recently researchers have identified that nuclear localized acetylcoenzyme A producing-enzymes, such as citrate lyase and pyruvate dehydrogenase complex, play important roles in histone acetylation (Sutendra et al. 2014) . HK2 may also possibly control the translocation of these enzymes to the nucleus, which is accountable for enhanced acetylated histones. However, whether HK2 can regulate these processes to promote neuroinflammatory responses should be further investigated to fully elucidate the specific role of HK2 on microglia neuroinflammation.
Collectively, our data demonstrate that the HK2 induction is crucial for hyperglycolysis-mediated noxious effect and the decisive role of HK2 in neuroinflammation presents itself as a promising target for the treatment of hypoxia-associated neural injuries, including acute ischemic stroke.
